# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Effective immediately, CPT 31242 is no longer considered experimental, removing a key barrier for ENT physicians treating chron...
Jefferies analyst David Windley maintains UnitedHealth Group (NYSE:UNH) with a Buy and raises the price target from $317 to ...
UnitedHealth Group (UNH) is in a trading range. Some traders will buy near the bottom and sell close to the top.
Texas court rules against Humana, upholding Medicare Advantage bonus cuts and risking billions in insurer revenue tied to star ...
Goldman Sachs analyst Scott Fidel initiates coverage on UnitedHealth Group (NYSE:UNH) with a Buy rating and announces Price...
https://www.bloomberg.com/news/articles/2025-10-09/unitedhealth-to-buy-medical-group-in-sign-optum-s-still-growing